A British drug company. Its AI research is based in King's Cross, London.
GSK has developed Phenformer, a software tool trained to read genomes. By linking genomic information with phenotypes—the bodily and behavioural outcomes of particular genetic combinations—Phenformer learns how genes drive disease and generates novel hypotheses about particular illnesses and their underlying mechanisms. Patrick Schwab leads development of the tool.
The firm also uses Cogito Forge, an AI agent-based system. Prompted with a question about biology, Cogito Forge can write its own code, gather appropriate datasets, glue them together and create a presentation complete with charts showing its conclusions. It can generate a testable hypothesis about a disease and attempt to verify or falsify it with a literature search, employing three agents: one to look for supporting evidence, a second to look for contradicting evidence, and a third to adjudicate. Kim Branson is head of AI at GSK.
inoculatte: To take coffee intravenously when you are running late.